Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 04635X102 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Glazer Capital, LLC
13G/A
|
6.6% |
2/12/2026
Event 12/31/2025
|
||
| Glazer Capital, LLC | 6.6% | |||
| Paul J. Glazer | 6.6% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (9) | ||||
|
Venrock Healthcare Capital Partners III, L.P.
13G/A
|
4.4% |
2/14/2025
Event 12/31/2024
|
||
| Venrock Healthcare Capital Partners III, L.P. | 4.4% | |||
| VHCP Co-Investment Holdings III, LLC | 4.4% | |||
| Venrock Healthcare Capital Partners EG, L.P. | 4.4% | |||
| VHCP Management III, LLC | 4.4% | |||
| VHCP Management EG, LLC | 4.4% | |||
| Nimish Shah | 4.4% | |||
| Bong Y Koh | 4.4% | |||
|
Fairmount Funds Management LLC
13G/A
|
4.0% |
10/15/2025
Event 10/14/2025
|
||
| Fairmount Funds Management LLC | 4.0% | |||
| Fairmount Healthcare Fund II GP LLC | 4.0% | |||
|
FMR LLC
13G/A
|
2.2% |
11/7/2025
Event 10/31/2025
|
||
| FMR LLC | 2.2% | |||
| Abigail P. Johnson | 2.2% | |||
|
Integrated Core Strategies (US) LLC
13G/A
|
0.4% |
10/20/2025
Event 10/14/2025
|
||
| Integrated Core Strategies (US) LLC | 0.3% | |||
| Millennium Management LLC | 0.4% | |||
| Millennium Group Management LLC | 0.4% | |||
| Israel A. Englander | 0.4% | |||
|
ForGrowth III PA B.V.
13G/A
|
0% |
11/14/2025
Event 10/16/2025
|
||
| ForGrowth III PA B.V. | 0% | |||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 0% | |||
| Forbion Growth III Management B.V. | 0% | |||
|
Magnetar Financial LLC
13D/A
|
0% |
1/28/2026
Event 1/26/2026
|
||
| Magnetar Financial LLC | 0% | |||
| Magnetar Capital Partners LP | 0% | |||
| Supernova Management LLC | 0% | |||
| David J. Snyderman | 0% | |||
|
Perceptive Advisors LLC
13D/A
|
0% |
2/9/2026
Event 1/26/2026
|
||
| Perceptive Advisors LLC | 0% | |||
| Joseph Edelman | 0% | |||
| Perceptive Life Sciences Master Fund, Ltd. | 0% | |||
| Perceptive Xontogeny Venture Fund, L.P. | 0% | |||
|
RA Capital Management, L.P.
13G/A
|
0% |
8/14/2025
Event 6/30/2025
|
||
| RA Capital Management, L.P. | 0% | |||
| Peter Kolchinsky | 0% | |||
| Rajeev Shah | 0% | |||
| RA Capital Healthcare Fund, L.P. | 0% | |||
|
Vestal Point Capital, LP
13G/A
|
0% |
2/17/2026
Event 12/31/2025
|
||
| Vestal Point Capital, LP | 0% | |||
| Ryan Wilder | 0% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q4 | 144 | 56.6 M | $739 M |
| 2025 Q3 | 122 | 59.2 M | $421 M |
| 2025 Q2 | 109 | 57.7 M | $311 M |
| 2025 Q1 | 121 | 58.4 M | $312 M |
| 2024 Q4 | 116 | 58.5 M | $523 M |
| 2024 Q3 | 109 | 56.6 M | $622 M |
| 2024 Q2 | 109 | 56.9 M | $518 M |
| 2024 Q1 | 130 | 58.1 M | $817 M |
| 2023 Q4 | 87 | 37.3 M | $286 M |
| 2023 Q3 | 71 | 23.0 M | $171 M |
| 2023 Q2 | 81 | 24.7 M | $205 M |
| 2023 Q1 | 70 | 23.4 M | $312 M |
| 2022 Q4 | 67 | 22.0 M | $327 M |
| 2022 Q3 | 44 | 9.83 M | $88.8 M |
| 2022 Q2 | 34 | 5.73 M | $17.2 M |
| 2022 Q1 | 38 | 6.21 M | $41.7 M |
| 2021 Q4 | 41 | 7.37 M | $39.7 M |
| 2021 Q3 | 38 | 7.21 M | $63.8 M |